Cargando…
An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
Methylphenidate (MPH) is the most commonly prescribed stimulant for children with ADHD. Data on the effects of different MPH formulations in real-life settings are scarce, and the role of previous therapy on treatment outcome when switching medications has not been well studied. OBSEER was an observ...
Autores principales: | Döpfner, Manfred, Breuer, Dieter, Walter, Daniel, Rothenberger, Aribert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098980/ https://www.ncbi.nlm.nih.gov/pubmed/21901414 http://dx.doi.org/10.1007/s00787-011-0205-1 |
Ejemplares similares
-
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
por: Döpfner, Manfred, et al.
Publicado: (2011) -
An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011) -
Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
por: Breuer, Dieter, et al.
Publicado: (2011) -
Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011) -
Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD
por: Becker, Andreas, et al.
Publicado: (2011)